BOI:EPA
Boiron USA
€ १९.००
arrow_upward
+१.६०%(+०.३०) 1D
नोभेम्बर २, १७:३५:०१ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€ १८.८५
High
€ १९.५०
Low
€ १८.७०
Mkt. cap
३३.३४ करोड
Avg. vol.
५.३७ हजार
Volume
३.७८ हजार
P/E ratio
१२.६०
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
Open
€ १८.८५
High
€ १९.५०
Low
€ १८.७०
Mkt. cap
३३.३४ करोड
Avg. vol.
५.३७ हजार
Volume
३.७८ हजार
P/E ratio
१२.६०
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Seeking Alpha
·
५७ मिनेट पहिले
How To Play The Midterms: Focus On This (SP500)
MarketWatch
·
१७ मिनेट पहिले
6 dividend stocks for investors who want to cut their exposure to the S&P 500
CNBC
·
१ घण्टा पहिले
Stock market after midterm elections: What S&P 500 history shows
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA